Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(1.11)
# 2027
Out of 5,370 analysts
620
Total ratings
35.29%
Success rate
-5.49%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IRON Disc Medicine | Reiterates: Buy | 118 118 | 51.94 | 127.19% | 15 | Jun 17, 2025 | |
CABA Cabaletta Bio | Reiterates: Buy | 25 25 | 1.94 | 1188.66% | 26 | Jun 11, 2025 | |
ARGX argenx | Reiterates: Buy | 720 720 | 551.73 | 30.5% | 38 | Jun 11, 2025 | |
PTGX Protagonist Therapeu... | Reiterates: Buy | 80 80 | 54.66 | 46.36% | 33 | Jun 3, 2025 | |
ROIV Roivant Sciences | Reiterates: Buy | 18 18 | 11.07 | 62.6% | 19 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 53 53 | 32.07 | 65.26% | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 105 105 | 43.77 | 139.89% | 23 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.78 | 797.44% | 25 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 14 14 | 4.36 | 221.1% | 17 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 34 34 | 15.93 | 113.43% | 16 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 27 27 | 9.93 | 171.9% | 27 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 19 19 | 13.38 | 42% | 4 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 3.04 | 294.74% | 17 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 3.98 | 352.26% | 14 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 51 51 | 15.48 | 229.46% | 22 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 0.87 | 1968.97% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 54 | 15.15 | 256.44% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 57 57 | 18.32 | 211.14% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 10.74 | 39.66% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 5 | 1.78 | 180.9% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 3 | 1.77 | 69.49% | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 46 46 | 29.41 | 56.41% | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 14 12 | 9.06 | 32.45% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 81 81 | 31.07 | 160.7% | 23 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 5 | n/a | n/a | 10 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | n/a | n/a | 19 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 7 7 | n/a | n/a | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 4.12 | 94.17% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 360 | n/a | n/a | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 41 45 | n/a | n/a | 6 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 2 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 6 | n/a | n/a | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 74 | n/a | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 10 | 1.12 | 792.86% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 48 30 | n/a | n/a | 2 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 10 | 29.61 | -66.23% | 7 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 162 220 | n/a | n/a | 5 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 14 | n/a | n/a | 6 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 53 | n/a | n/a | 9 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | n/a | n/a | 7 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 168 182 | 146.97 | 23.83% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 19 | 6.73 | 178.6% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 25 18 | 24.69 | -27.1% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | n/a | n/a | 5 | Aug 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underweight | 8 | 17.5 | -54.29% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | n/a | n/a | 3 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 52 | 24.29 | 114.08% | 2 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 34 0 | n/a | n/a | 6 | Jun 6, 2018 |